Related Experiment Video
Updated: Dec 13, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Accelerated and intensified calcific atherosclerosis and microvascular dysfunction in patients with chronic kidney
Meer Fakhry1, Mandeep S Sidhu2, Sripal Bangalore3
1Department of Medicine, University of South Carolina School of Medicine, Columbia, SC 29208, USA.
Insights
Coronary artery disease (CAD) in chronic kidney disease (CKD) patients presents uniquely, often silently. Key features include increased coronary artery calcification (CAC) and microcirculatory dysfunction, impacting heart function.
Area of Science:
- Nephrology
- Cardiology
- Vascular Biology
Background:
- Cardiovascular disease (CVD), especially coronary artery disease (CAD), is a major cause of death in chronic kidney disease (CKD) patients.
- CAD in CKD exhibits distinct features compared to the general population, including reduced symptom presentation and therapeutic response.
- Unique pathological characteristics of CAD in CKD include heightened coronary artery calcification (CAC) and impaired coronary microcirculatory function.
Purpose of the Study:
- To investigate the unique characteristics of coronary artery disease (CAD) in patients with chronic kidney disease (CKD).
- To explore the roles of coronary artery calcification (CAC) and coronary microcirculatory dysfunction in CAD among CKD patients.
- To understand the combined impact of CAC and microcirculatory dysfunction on myocardial function and silent myocardial infarction in CKD.
Main Methods:
- Review of existing literature on CAD in CKD patients.
- Analysis of pathophysiological pathways contributing to CAC in CKD.
- Examination of the pathophysiology of coronary microcirculatory dysfunction in CKD.
- Assessment of the relationship between CAC and microcirculatory dysfunction.
Main Results:
- Patients with CKD exhibit increased calcific density of atherosclerotic plaques and vessels (CAC).
- Coronary microcirculatory dysfunction is prevalent in CKD patients with CAD.
- The interplay between CAC and microcirculatory dysfunction contributes to more severe impacts on myocardial function.
- These factors may explain the higher incidence of silent myocardial infarction in CKD.
Conclusions:
- CAD in CKD possesses unique features, notably increased CAC and microcirculatory dysfunction.
- Further research is essential to elucidate the pathophysiology and therapeutic strategies for CAD in CKD.
- Understanding these unique aspects is crucial for managing cardiovascular risk in CKD patients.
Abstract:
Cardiovascular disease, and in particular coronary artery disease (CAD), remains an important contributor of morbidity and mortality among patients with chronic kidney disease (CKD). Classic symptomatology of CAD and effectiveness of established therapeutic measures is less frequent in patients with CKD. This suggests unique characteristics of CAD among patients with CKD. Two important features of CAD in CKD include increased calcific density of atherosclerotic plaques and of the vessels themselves (coronary artery calcification -- CAC), as well as a decrease in microcirculatory function -- or coronary microcirculatory dysfunction. A multitude of pathophysiologic pathways have been identified that contribute to CAC in CKD; less is known about the pathophysiology of microcirculatory dysfunction. It is not well established if these two processes are directly related to each other, but the combination results in a greater severity of effect on overall myocardial function and may in part explain the greater preponderance of silent myocardial infarction. Further investigation is needed to better understand these unique aspects of CAD in CKD as well as the role they play in overall CVD in this group, and ultimately therapeutics that may lessen the burden of disease.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Peripheral Artery Disease I: Introduction
Acute Kidney Injury II: Pathophysiology

